Susquehanna International Group
NVNO

Susquehanna International Group’s enVVeno Medical NVNO Stock Holding History

Susquehanna International Group’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,781
Closed -$42.5K – 13830
2025
Q4 		$42.5K Sell
3,781
-632
-14% -$12.3K ﹤0.01% 11806
2025
Q3 		$140K Buy
+4,413
New +$451K ﹤0.01% 11332
2024
Q4 		– Sell
-546
Closed -$64.2K – 12897
2024
Q3 		$64.2K Buy
+546
New +$100K ﹤0.01% 11282
2024
Q1 		– Sell
-533
Closed -$95.6K – 12974
2023
Q4 		$96K Sell
533
-1,153
-68% -$184K ﹤0.01% 11361
2023
Q3 		$318K Sell
1,686
-150
-8% -$25K ﹤0.01% 9221
2023
Q2 		$198K Buy
1,836
+602
+49% +$78.2K ﹤0.01% 10283
2023
Q1 		$204K Buy
1,234
+149
+14% +$27.8K ﹤0.01% 10546
2022
Q4 		$194K Buy
+1,085
New +$220K ﹤0.01% 10169
2022
Q3 		– Sell
-319
Closed -$67.9K – 13834
2022
Q2 		$42K Buy
+319
New +$49.5K ﹤0.01% 12071
2020
Q2 		– Sell
-26
Closed -$7K – 10663
2020
Q1 		$7K Buy
+26
New +$12.3K ﹤0.01% 10073
2018
Q4 		– Sell
-12
Closed -$29K – 9659
2018
Q3 		$29K Buy
+12
New +$27.8K ﹤0.01% 8949

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group's NVNO Position: Q1 2026 in Review

Susquehanna International Group sold out of enVVeno Medical (NVNO) in Q1 2026, closing a stake of 3,781 shares — an estimated $42.5K sold.

Susquehanna International Group first reported a position in NVNO in Q3 2018 and held it in 11 quarters. The position peaked at $318K in Q3 2023. 17 funds tracked by Wall St. Rank hold NVNO as of Q1 2026.

  • Susquehanna International Group reported no remaining enVVeno Medical position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 3,781 enVVeno Medical shares in Q1 2026, an estimated $42.5K.
  • Susquehanna International Group first reported a position in enVVeno Medical in Q3 2018 and held it in 11 quarters.
  • Susquehanna International Group's enVVeno Medical position peaked at $318K in Q3 2023.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.